The Andersons (ANDE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
11 Mar, 2026Executive summary
Annual meeting scheduled for May 7, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 6, 2026, or May 4, 2026, for plan shares.
Voting matters and shareholder proposals
Election of nine directors is on the agenda, with board recommendations provided for each nominee.
Advisory vote on executive compensation is included, with board recommending approval.
Ratification of Deloitte & Touche LLP as independent auditor for the year ending December 31, 2026, is proposed.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Director nominees include William E. Krueger, Patrick E. Bowe, Gerard M. Anderson, Steven K. Campbell, Gary A. Douglas, Pamela S. Hershberger, Catherine M. Kilbane, Robert J. King Jr., and Steven Oakland.
Latest events from The Andersons
- Strong 2026 results and strategic growth initiatives support a 2028 EPS target of $7.00.ANDE
Investor presentation - Record Q2 2026 earnings and cash flow driven by Renewables and improved Agribusiness margins.ANDE
Q2 2026 - Growth, diversification, and export strength underpin confidence in a $7 EPS target by 2028.ANDE
21st Annual Global Farm to Market Conference - Strong growth in ag and renewables, targeting $7.00 EPS by 2028 through strategic investments.ANDE
Investor presentation - All board nominees elected, compensation approved, and auditors ratified for 2026.ANDE
AGM 2026 - Record Q1 net income and EBITDA driven by Renewables, Agribusiness, and clean fuel credits.ANDE
Q1 2026 - Virtual meeting to elect nine directors, approve pay, and ratify auditor, with strong governance focus.ANDE
Proxy Filing - Record Q4 EPS and renewables growth, with strong outlook and ongoing capital investments.ANDE
Q4 2025 - Record Trade and Renewables performance drove $114M net income and $363M EBITDA.ANDE
Q4 2024